Danish drugmaker Novo Nordisk on Tuesday announced slashing prices of its weight-loss drug Wegovy by up to 37 per cent in a ...

Danish healthcare company Novo Nordisk has dropped prices for its weight-loss and diabetes drug Wegoy, the injectable ...

Novo Nordisk India reduces the price of its obesity medication Wegovy by 37%. Starting dose now available at Rs 2,712 per week.

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, the second brand of Wegovy.

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...

Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to ...

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...